Clinical Watch: May 2018

May 24, 2018

In this issue of Clinical Watch, we discuss recently approved HIV-1 therapies. We suggest criteria for a new drug treatment for glaucoma and review a study evaluating the cardiovascular safety of three newer oral antihyperglycemic classes. Lastly, we review claims data to evaluate utilization trends with gabapentin and with gabapentin and opioids.

For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
Clinical Watch: June 2018
Clinical Watch: June 2018

Next Flipbook
Everest Group PEAK Matrix for Healthcare Payer BPO Service Providers
Everest Group PEAK Matrix for Healthcare Payer BPO Service Providers